| Lipocalin 2 protects from inflammation and tumorigenesis associated with gut microbiota alterations AR Moschen, RR Gerner, J Wang, V Klepsch, TE Adolph, SJ Reider, ... Cell host & microbe 19 (4), 455-469, 2016 | 290 | 2016 |
| Auto-aggressive CXCR6+ CD8 T cells cause liver immune pathology in NASH M Dudek, D Pfister, S Donakonda, P Filpe, A Schneider, M Laschinger, ... Nature 592 (7854), 444-449, 2021 | 287 | 2021 |
| The anterolateral ligament of the knee: a dissection study A Runer, S Birkmaier, M Pamminger, S Reider, E Herbst, KH Künzel, ... The Knee 23 (1), 8-12, 2016 | 98 | 2016 |
| Prebiotic effects of partially hydrolyzed guar gum on the composition and function of the human microbiota—Results from the PAGODA Trial SJ Reider, S Moosmang, J Tragust, L Trgovec-Greif, S Tragust, L Perschy, ... Nutrients 12 (5), 1257, 2020 | 57 | 2020 |
| Faecal biomarkers in inflammatory bowel diseases: calprotectin versus lipocalin-2—a comparative study A Zollner, A Schmiderer, SJ Reider, G Oberhuber, A Pfister, B Texler, ... Journal of Crohn's and Colitis 15 (1), 43-54, 2021 | 50 | 2021 |
| Microbial butyrate synthesis indicates therapeutic efficacy of azathioprine in IBD patients M Effenberger, S Reider, S Waschina, C Bronowski, B Enrich, TE Adolph, ... Journal of Crohn's and Colitis 15 (1), 88-98, 2021 | 47 | 2021 |
| Dimethyl fumarate ameliorates hepatic inflammation in alcohol related liver disease M Sangineto, F Grabherr, TE Adolph, C Grander, S Reider, N Jaschke, ... Liver International 40 (7), 1610-1619, 2020 | 27 | 2020 |
| Targeting NAD immunometabolism limits severe graft-versus-host disease and has potent antileukemic activity RR Gerner, S Macheiner, S Reider, K Siegmund, F Grabherr, L Mayr, ... Leukemia 34 (7), 1885-1897, 2020 | 19 | 2020 |
| Uterine microbiota plasticity during the menstrual cycle: Differences between healthy controls and patients with recurrent miscarriage or implantation failure K Vomstein, S Reider, B Böttcher, C Watschinger, C Kyvelidou, H Tilg, ... Journal of Reproductive Immunology 151, 103634, 2022 | 18 | 2022 |
| Increased fecal neopterin parallels gastrointestinal symptoms in COVID-19 F Grabherr, M Effenberger, A Pedrini, L Mayr, J Schwaerzler, S Reider, ... Clinical and translational gastroenterology 12 (1), e00293, 2021 | 15 | 2021 |
| Tofacitinib-induced modulation of intestinal adaptive and innate immunity and factors driving cellular and systemic pharmacokinetics B Texler, A Zollner, V Reinstadler, SJ Reider, S Macheiner, B Jelusic, ... Cellular and Molecular Gastroenterology and Hepatology 13 (2), 383-404, 2022 | 13 | 2022 |
| Short- and Long-Term Effects of a Prebiotic Intervention with Polyphenols Extracted from European Black Elderberry—Sustained Expansion of Akkermansia spp. S Reider, C Watschinger, J Längle, U Pachmann, N Przysiecki, A Pfister, ... Journal of personalized medicine 12 (9), 1479, 2022 | 10 | 2022 |
| Digital workout versus team training: The impact of the COVID-19 pandemic on athletes F Schneider, A Runer, F Burkert, JSU Aspang, S Reider, H Schneider, ... Sports medicine international open 6 (01), E18-E24, 2022 | 7 | 2022 |
| Aggressive local treatment for recurrent intrahepatic cholangiocarcinoma—Stereotactic radiofrequency ablation as a valuable addition to hepatic resection E Braunwarth, P Schullian, M Kummann, S Reider, D Putzer, F Primavesi, ... Plos one 17 (1), e0261136, 2022 | 6 | 2022 |
| A long-term follow-up study on otoacoustic emissions testing in paediatric patients with severe malaria in Gabon E Reiterer, S Reider, P Lackner, N Fischer, D Dejaco, H Riechelmann, ... Malaria Journal 18, 1-10, 2019 | 6 | 2019 |
| Hematopoietic Stem Cell Transplantation in Refractory Crohn’s Disease: Should It Be Considered? S Reider, L Binder, S Fürst, S Hatzl, A Blesl Cells 11 (21), 3463, 2022 | 5 | 2022 |
| Author Correction: Auto-aggressive CXCR6+ CD8 T cells cause liver immune pathology in NASH M Dudek, D Pfister, S Donakonda, P Filpe, A Schneider, M Laschinger, ... Nature 593 (7860), E14-E14, 2021 | 3 | 2021 |
| Prediction of response to systemic corticosteroids in active UC by microbial composition—a prospective multicenter study A Blesl, P Wurm, S Waschina, HP Gröchenig, G Novacek, C Primas, ... Inflammatory Bowel Diseases 30 (1), 9-19, 2024 | 2 | 2024 |
| Metabolomic predictors of response to vedolizumab in Inflammatory Bowel Disease S Reider, C Watschinger, R Koch, H Tilg, A Moschen JOURNAL OF CROHNS & COLITIS 18, I522-I522, 2024 | | 2024 |
| P206 Metabolomic predictors of response to vedolizumab in Inflammatory Bowel Disease S Reider, C Watschinger, R Koch, H Tilg, A Moschen Journal of Crohn's and Colitis 18 (Supplement_1), i527-i527, 2024 | | 2024 |
